Literature DB >> 2040792

Tolerance susceptibility of newly generating memory B cells.

P J Linton1, A Rudie, N R Klinman.   

Abstract

Newly generating memory B cells rapidly accumulate somatic mutations that can alter their Ag-combining sites and potentially engender recognition of self determinants. To investigate the possibility that, during their emergence secondary B cells pass through a window of tolerance susceptibility, we have examined the in vitro generation of memory B cells in the presence or absence of tolerogen. The findings indicate that, before antigenic stimulation, precursors to memory B cells are resistant to tolerance induction. However, 2 to 7 days after T cell-dependent antigenic stimulation, newly emerging hapten-specific secondary B cells can be inactivated by the presence of hapten on a carrier not recognized by available Th cells. This inactivation can be blocked by the presence of free hapten and can be competed by the presence of immunogen. Inactivation of newly generating secondary B cells appears less specific than the tolerance induction of immature neonatal or bone marrow B cells because inactivation can be accomplished by cross-reactive determinants. Interestingly, the presence of tolerogen after primary stimulation did not preclude the generation of cells responsive to a third in vitro stimulation. Therefore, whereas newly emerging memory B cells are highly susceptible to inactivation, the progression of the clones of progenitors to memory B cells appears resistant to tolerance induction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040792

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Relative roles of somatic and Darwinian evolution in shaping the antibody response.

Authors:  M Diaz; N R Klinman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Evolution and the molecular basis of somatic hypermutation of antigen receptor genes.

Authors:  M Diaz; M F Flajnik; N Klinman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 3.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

4.  Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease.

Authors:  S K Ray; C Putterman; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

Review 5.  Antigen receptor 'capacity' and the sensitivity of self-tolerance.

Authors:  D Nemazee
Journal:  Immunol Today       Date:  1996-01

6.  Autoantigen Tetramer Silences Autoreactive B Cell Populations.

Authors:  Matthew A Christopher; Stephanie N Johnson; J Daniel Griffin; Cory J Berkland
Journal:  Mol Pharm       Date:  2020-10-06       Impact factor: 4.939

7.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

Authors:  Amedeo Cappione; Jennifer H Anolik; Aimee Pugh-Bernard; Jennifer Barnard; Paul Dutcher; Gregg Silverman; Iñaki Sanz
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

8.  Soluble antigen profoundly reduces memory B-cell numbers even when given after challenge immunization.

Authors:  G J Nossal; M Karvelas; B Pulendran
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.

Authors:  M Børretzen; I Randen; E Zdárský; O Førre; J B Natvig; K M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Memory cell generation ablated by soluble protein antigen by means of effects on T- and B-lymphocyte compartments.

Authors:  M Karvelas; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.